Deferasirox in the management of iron‐overload in patients with myelofibrosis: a multicentre study from the Rete Ematologica Lombarda ( IRON ‐M study)-Reference-Cited by-同舟云学术

Deferasirox in the management of iron‐overload in patients with myelofibrosis: a multicentre study from the Rete Ematologica Lombarda ( IRON ‐M study)

Published:2019-05-20 Issue:5 Volume:186 Page:
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Elli Elena M.¹^ORCID,Iurlo Alessandra²^ORCID,Aroldi Andrea¹,Caramella Marianna³,Malato Simona⁴,Casartelli Elena⁵,Maffioli Margherita⁶,Gardellini Angelo⁷,Carraro Maria C.⁸,D'Adda Mariella⁹,Polverelli Nicola¹⁰^ORCID,Rossi Marianna¹¹,Orofino Nicola²,Carrer Andrea¹,Gambacorti‐Passerini Carlo¹,Antolini Laura¹²,Passamonti Francesco⁶

Affiliation:

1. Haematology Division and Bone Marrow Unit Ospedale San Gerardo Monza Italy

2. Haematology Division IRCCS Cà Granda – Maggiore Policlinico Hospital Foundation Milano Italy

3. Departent of Haematology Ospedale Niguarda Cà Granda Milano Italy

4. Haematology and Bone Marrow Transplantation Unit San Raffaele Scientific Institute Milano Italy

5. Haematology and Transfusion Medicine ASST Lecco Lecco Italy

6. Haematology Department of Medicine and Surgery University of Insubria & Ospedale di Circolo ASST Sette Laghi Varese Italy

7. Haematology Ospedale Valduce Como Italy

8. Haematology and Transfusion Medicine Sacco Hospital Milano Italy

9. Department of Haematology ASST Spedali Civili Brescia Italy

10. Haematology Bone Marrow Transplantation Unit Department of Clinical and Experimental Sciences University of Brescia Brescia Italy

11. Cancer Centre Humanitas Research Hospital & Humanitas University Milan Italy

12. Centro di Biostatistica per l'epidemiologia clinica Department of Health Sciences University of Milano‐Bicocca Monza Italy

Funder

Fondazione Regionale Ricerca Biomedica, Milan, Italy

Fondazione Matarelli

Fondazione Rusconi

AIL Varese ONLUS

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.15964

Reference9 articles.

1. Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia

2. Correction of anemia in a transfusion-dependent patient with primary myelofibrosis receiving iron chelation therapy with deferasirox (Exjade�, ICL670)

3. IRON CHELATION THERAPY WITH DEFERASIROX IN THE MANAGEMENT OF IRON OVERLOAD IN PRIMARY MYELOFIBROSIS

4. Iron toxicity – Its effect on the bone marrow

5. Chelation efficacy and erythroid response during deferasirox treatment in patients with myeloproliferative neoplasms in fibrotic phase

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ACVR1: A Novel Therapeutic Target to Treat Anemia in Myelofibrosis;Cancers;2023-12-28

2. Treatment of anemia in myelofibrosis: focusing on novel therapeutic options;Expert Opinion on Investigational Drugs;2023-12-10

3. Luspatercept: A New Tool for the Treatment of Anemia Related to β-Thalassemia, Myelodysplastic Syndromes and Primary Myelofibrosis;Diseases;2022-10-09

4. Iron overload disorders;Hepatology Communications;2022-06-14

5. Deferasirox in the management of iron overload in patients with myelofibrosis treated with ruxolitinib: The multicentre retrospective RUX‐IOL study;British Journal of Haematology;2022-02-08